BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Castle Biosciences 



Houston  Texas    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Diagnostics






 Company News
Castle Biosciences Announces Data Demonstrating Ability To Identify Esophageal Cancer Patients Resistant To Standard Pre-Surgical Treatment Of Chemotherapy And Radiation 1/16/2014 10:20:58 AM    More...
Castle Biosciences Launches Tissue Repository for Eye Cancer Patients 9/30/2013 9:39:21 AM    More...
Castle Biosciences Genetic Test Highly Accurate in Differentiating Thymomas From Thymic Carcinoma Tumors 9/25/2013 10:31:20 AM    More...
Castle Biosciences Release: Gene Test Identifies Non-Metastatic Melanoma Patients at High Risk of Recurrence 8/5/2013 9:43:31 AM    More...
Castle Biosciences Release: New Website Dedicated to Patients With Thymic Cancer 7/30/2013 7:44:52 AM    More...
Castle Biosciences Release: Gene Test Highly Accurate in Predicting Metastasis in Patients With Thymoma 7/25/2013 9:23:19 AM    More...
Castle Biosciences Announces Availability of DecisionDx-Melanoma Test to Identify Stage I & II Melanoma Patients at High Risk of Metastasis 6/3/2013 11:09:05 AM    More...
Castle Biosciences Licenses Thymoma Test Technology; Availability on Track for End of 1st Quarter of 2012 1/25/2012 8:58:23 AM    More...
Castle Biosciences Announces Availability of DecisionDx-GBM Biomarker Test for Brain Cancer (Glioblastoma Multiforme) Patients that Predicts Overall Survival to First-Line Standard of Care Treatment 7/16/2009 11:43:06 AM    More...
Castle Biosciences, a Biomarker Based Cancer Diagnostics Company, Announces Appointment of Derek Maetzold as President and CEO 9/26/2008 8:27:19 AM    More...

//-->